DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,572 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $348,541 | +1.3% | 1,395 | +1.2% | 0.03% | 0.0% |
Q1 2024 | $344,114 | +7.9% | 1,378 | 0.0% | 0.03% | -3.4% |
Q4 2023 | $318,787 | -6.8% | 1,378 | 0.0% | 0.03% | -14.7% |
Q3 2023 | $341,882 | -2.3% | 1,378 | -5.5% | 0.03% | +6.2% |
Q2 2023 | $349,920 | -6.1% | 1,458 | -1.4% | 0.03% | -5.9% |
Q1 2023 | $372,515 | -6.7% | 1,478 | -1.8% | 0.03% | -8.1% |
Q4 2022 | $399,457 | +3.0% | 1,505 | 0.0% | 0.04% | 0.0% |
Q3 2022 | $388,000 | +1.8% | 1,505 | 0.0% | 0.04% | +8.8% |
Q2 2022 | $381,000 | -22.2% | 1,505 | -9.9% | 0.03% | -12.8% |
Q1 2022 | $490,000 | -10.9% | 1,671 | 0.0% | 0.04% | -7.1% |
Q4 2021 | $550,000 | +8.1% | 1,671 | 0.0% | 0.04% | +2.4% |
Q3 2021 | $509,000 | +26.0% | 1,671 | +11.0% | 0.04% | +28.1% |
Q2 2021 | $404,000 | +19.5% | 1,505 | 0.0% | 0.03% | +14.3% |
Q1 2021 | $338,000 | +1.2% | 1,505 | 0.0% | 0.03% | -6.7% |
Q4 2020 | $334,000 | -0.3% | 1,505 | -3.2% | 0.03% | -9.1% |
Q3 2020 | $335,000 | +21.8% | 1,555 | 0.0% | 0.03% | +17.9% |
Q2 2020 | $275,000 | +27.9% | 1,555 | 0.0% | 0.03% | +7.7% |
Q1 2020 | $215,000 | -18.3% | 1,555 | -9.3% | 0.03% | +4.0% |
Q4 2019 | $263,000 | +6.0% | 1,715 | 0.0% | 0.02% | +4.2% |
Q3 2019 | $248,000 | +31.9% | 1,715 | +30.4% | 0.02% | +26.3% |
Q2 2019 | $188,000 | +8.7% | 1,315 | 0.0% | 0.02% | +5.6% |
Q1 2019 | $173,000 | +28.1% | 1,315 | 0.0% | 0.02% | +20.0% |
Q4 2018 | $135,000 | -5.6% | 1,315 | 0.0% | 0.02% | +7.1% |
Q3 2018 | $143,000 | -43.9% | 1,315 | -60.7% | 0.01% | -61.1% |
Q3 2014 | $255,000 | -3.8% | 3,348 | -0.9% | 0.04% | +20.0% |
Q2 2014 | $265,000 | -39.9% | 3,378 | -42.5% | 0.03% | -41.2% |
Q1 2014 | $441,000 | -8.1% | 5,878 | -5.5% | 0.05% | -10.5% |
Q4 2013 | $480,000 | +5.5% | 6,223 | -5.0% | 0.06% | 0.0% |
Q3 2013 | $455,000 | +9.6% | 6,552 | 0.0% | 0.06% | +5.6% |
Q2 2013 | $415,000 | – | 6,552 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |